Weighted Average Number of Shares Outstanding, Diluted of Evoke Pharma Inc from Q2 2016 to Q3 2025
-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Evoke Pharma Inc quarterly and annual Weighted Average Number of Shares Outstanding, Diluted history and change rate from Q2 2016 to Q3 2025.
- Evoke Pharma Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Sep 2025 was 2,557,408, a 83% increase year-over-year.
- Evoke Pharma Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 1,905,072, a 584% increase from 2023.
- Evoke Pharma Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 278,558, a 91% decline from 2022.
- Evoke Pharma Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 3,143,626, a 17% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)